APVO News and Press, Aptevo Therapeutics Inc. From 08/10/23

Positive Duration of Remission Data Adds to Growing Body of Clinical Evidence Supporting APVO436 for the Treatment of AML APVO436 Poised for Phase 2 Trial Initiation Later in 2H23 Company Completes $5 million Equity Raise, Extending Cash Runway into 3Q24 SEATTLE, WA / ACCESSWIRE / A...

SEATTLE, WA / ACCESSWIRE / August 4, 2023 / Aptevo Therapeutics Inc. (NASDAQ:APVO) ("Aptevo" or the "Company"), a clinical stage biotechnology company focused on developing novel immuno-oncology therapeutics, today announced the closing of its previously announced public offering of 2,221,550 sh...

2023-08-02 09:48:19 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Advanced Micro Devices (NASDAQ: AMD ) stock is in the news Wednesday as investors wonder if the tech company can succeed in the artificial intelligence ( AI ) market. AM...

2023-08-02 09:26:24 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Match Group (NASDAQ: MTCH ) stock is on the move Wednesday after getting a new price prediction from BTIG analyst Jake Fuller. According to the analysts, shares of MTCH ...

2023-08-02 08:58:27 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Aptevo Therapeutics (NASDAQ: APVO ) stock is sliding lower on Wednesday after the biotechnology company announced a public share offering . The APVO stock offering has t...

2023-08-02 05:35:42 ET Aptevo Therapeutics ( NASDAQ: APVO ) stock price dropped 25% as the company entered agreements with healthcare-focused institutional investors for the purchase and sale of ~8M shares at a purchase price of $0.62 per share. The company further agree...

SEATTLE, WA / ACCESSWIRE / August 1, 2023 / Aptevo Therapeutics Inc. (NASDAQ:APVO) ("Aptevo" or the "Company"), a clinical stage biotechnology company focused on developing novel immuno-oncology therapeutics, today announced that the Company has entered into definitive agreements with healthcare...

2023-07-19 10:22:17 ET Gainers: Panbela Therapeutics ( PBLA ) +36% . 60 Degrees Pharmaceuticals ( SXTP ) +20% . CareMax ( CMAX ) +20% . Biodexa Pharmaceuticals ( BDRX ) +13% . bluebird bio ( BLUE ) +13% . Losers: Amar...

2023-07-18 10:13:56 ET Gainers: iCAD ( ICAD ) +31% . Biophytis ( BPTS ) +27% . Hyperfine ( HYPR ) +15% . Cabaletta Bio ( VERU ) +12% . Mind Medicine (MindMed) ( MNMD ) +10% . Losers: Lixte Biotechnology ( LIXT ) ...

Phase 2 Trials in Relapsed/Refractory and Frontline Settings Planned, APVO436 to be administered in Combination with Emerging Standard of Care New Data Adds to Growing Body of Clinical Evidence in Support of APVO436 Clinical Potential SEATTLE, WA / ACCESSWIRE / July 18, 2023 / Aptevo Th...